Key Takeaways
- Companies maintaining dual brand and performance investment showed 31% higher average revenue growth over 36 months versus performance-only peers.
- The advantage compounds over time: the gap was 9% in year one and widened to 31% by year three, driven by lower acquisition costs and shorter sales cycles.
- Brand investment reduces sales cycle length by an average of 18% among companies with high consideration scores in their target segments.
- Below a 20% brand spend threshold, the compounding benefits fail to materialise. Researchers recommend a starting range of 30 to 40% of total marketing budget.
How a Flawed Framing Took Hold of B2B Marketing
The boardroom version of this debate is familiar to almost every CMO working today. When budgets tighten, a CFO leans across the table and asks some version of the same question: which of these activities is actually driving revenue? Brand spend, with its longer time horizons and softer attribution signals, rarely survives that framing. Performance spend, with its click-through rates and pipeline influence dashboards, tends to win.
The problem is that this framing was always a simplification, and new research suggests it may be actively damaging the growth trajectories of a significant proportion of B2B companies. A study published this quarter by the B2B Institute and research partners across North America and Europe followed 300 companies over 36 months, tracking brand health metrics alongside pipeline velocity, conversion rates, and revenue growth. The findings are difficult to ignore.
Among companies that maintained meaningful investment in both brand and performance channels throughout the study period, average revenue growth ran 31 percent higher than among companies that had deprioritised brand spend to focus resources on measurable demand capture. The gap widened over time rather than narrowing, which points to a compounding dynamic that short-term measurement frameworks fail to capture.
What the Study Actually Measured
The methodology deserves some attention, because one objection to brand investment research is that it tends to be funded or influenced by media owners with a stake in the outcome. This study was designed with a different set of controls. Researchers segmented companies by sector, employee count, and average deal size to ensure comparisons were made within meaningful peer groups. They also tracked brand health through independent buyer surveys rather than relying on the self-reported data that marketing teams naturally skew optimistic.
Brand health in this context was defined across four dimensions: unaided awareness, category association strength, trust scoring, and purchase consideration among buyers who were not yet in an active evaluation cycle. That last metric, out-of-market consideration, turned out to be one of the strongest predictors of downstream conversion rate improvement. Companies that maintained high scores among buyers who were six to eighteen months from a purchase decision converted significantly better when those buyers eventually entered the market, because the relationship was not starting from zero.
Performance-only companies, by contrast, showed strong conversion rates on already-engaged traffic but paid substantially more per acquired customer over the study period. Without the latent demand created by brand investment, they were competing harder for a smaller pool of in-market buyers, driving up cost-per-acquisition as they scaled.
Higher average revenue growth among B2B companies that maintained dual brand and performance investment versus those that deprioritised brand spend over a 36-month study period.
The Compounding Effect: Why the Gap Widens Over Time
One of the more counterintuitive findings in the data is that the brand-plus-performance advantage does not plateau. In year one of the study period, the revenue gap between dual-investment companies and performance-only peers was modest, sitting at around nine percent. By year three, that gap had expanded to 31 percent and was still growing. This trajectory matters enormously for how CMOs should be framing the internal case for brand investment.
The mechanism behind compounding appears to work through three channels. First, brand familiarity reduces sales cycle length. When buyers already have a positive association with a vendor before a rep reaches out, the early stages of the sales process compress. The study found sales cycles ran an average of 18 percent shorter for companies with high brand consideration scores among their target segments. Second, brand strength insulates against price pressure. Buyers with strong vendor associations are less likely to require heavy discounting to close, protecting margin as scale increases.
Third, and most significant for long-term growth, brand investment creates a self-reinforcing awareness loop that reduces the reliance on paid acquisition channels over time. Companies with mature brand programs in the study were able to grow pipeline from organic, referral, and partner channels at higher rates than their performance-first peers, reducing their dependency on ad spend precisely when platform costs were rising. That structural efficiency advantage accelerates the gap with every passing quarter.
Building the Internal Case for Dual Investment
Understanding the data is one thing. Getting a CFO or board to approve meaningful brand spend alongside a performance budget is a different kind of problem, one that is as much about communication architecture as it is about evidence. The CMOs who navigated this successfully in the study cohort shared several common approaches.
The most effective tactic was reframing brand investment not as a cost of awareness but as a cost of sales efficiency. When brand spend is presented in terms of its downstream effect on cost-per-acquisition, sales cycle length, and win rates rather than reach and impressions, the conversation shifts from intangible to operational. Several marketing leaders in the study reported bringing sales leadership into this reframing process deliberately, using CRM data to show how deals from warm, brand-aware prospects behaved differently from cold outbound conversions.
A second approach involved proposing a controlled investment period with agreed measurement checkpoints rather than asking for permanent budget allocation. This lowered the perceived risk for finance partners who were uncomfortable with the longer time horizons that brand investment requires. Running a 12-month pilot with clear before-and-after brand health surveys, tied to pipeline and conversion data, gave CMOs a data asset they could use to argue for sustained investment in subsequent budget cycles.
Shorter average sales cycles among companies with high brand consideration scores in their target segments, compared to peers with low brand investment.
Practical Budget Allocation Guidance for B2B Teams
The study did not prescribe a universal split between brand and performance spend, and for good reason. The optimal ratio varies considerably by deal complexity, category maturity, and competitive intensity. What the data does support is a minimum viable brand investment threshold below which the compounding benefits fail to materialise. Companies spending less than 20 percent of their total marketing budget on brand-building activity showed no statistically significant improvement in the metrics the study tracked relative to performance-only peers.
For most mid-market B2B companies, researchers suggested a starting range of 30 to 40 percent of total marketing spend allocated to brand activity, defined as campaigns with a primary objective of building awareness, association, and consideration rather than capturing in-market intent. This range is deliberately conservative relative to B2C norms, where brand investment often exceeds 60 percent, but it is significantly higher than the single-digit percentages that many B2B marketing teams are working with today.
The channel mix within that brand allocation matters less than the consistency of investment. Companies that spent steadily on brand across multiple channels throughout the study period outperformed those that concentrated larger budgets into shorter burst campaigns. Continuity of presence, particularly among buyers who are not yet in an active buying cycle, appears to be more valuable than intensity of presence among buyers who already are.
What This Means for CMOs Under Pressure to Perform
The practical implication of this research is not that performance marketing should be deprioritised. The companies that performed best in the study ran rigorous, well-optimised demand capture programs alongside their brand work. The point is that treating these as competing priorities, a choice forced by budget constraints and reinforced by attribution frameworks that favour short-cycle activity, creates a structural disadvantage that accumulates over time.
For CMOs who have already trimmed brand spend to protect measurable pipeline numbers, the path back is not necessarily expensive. The study found that restoring brand investment to the minimum viable threshold, even after a period of underinvestment, began to show positive brand health signals within two quarters. The compounding benefits take longer to rebuild than they do to establish initially, which is an argument for protecting brand budgets aggressively rather than treating them as the first line of defence.
The most durable lesson from this data is a simple one. When the CFO frames the question as brand or performance, the correct answer is neither. The correct answer is that the question itself is a false choice, and the evidence to support that position has never been stronger than it is now.


